Education
About Us
Working with TipRanks
Follow Us
United Therapeutics (UTHR)
NASDAQ:UTHR
Earnings Data
Report Date
Oct 29, 2025Before Open (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
7.31Last Year’s EPS
6.39Same Quarter Last Year
Moderate Buy
Based on 12 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call presented a balanced perspective with strong financial results and strategic initiatives, including record revenue growth and pipeline advancements. However, competitive challenges and concerns regarding market perceptions and regulatory hurdles were also highlighted.Company Guidance
Record-Breaking Revenue Growth
United Therapeutics reported record total revenue of $799 million, reflecting a 12% growth over the second quarter of 2024. This marks the 12th consecutive quarter of double-digit year-over-year revenue growth.
Tyvaso DPI Performance
Tyvaso DPI achieved a record total revenue of $315 million, representing 22% growth over the second quarter of 2024, with record patient shipments and strong market dynamics.
Strategic Share Repurchase
The Board of Directors authorized the repurchase of up to $1 billion in shares through March of next year, indicating confidence in the company's financial position and future growth.
Pipeline Development and Innovation
Progress in the TETON studies for idiopathic pulmonary fibrosis and the ADVANCE OUTCOMES study in pulmonary arterial hypertension, with expected data readouts that could significantly impact the company's revenue profile.
Financial Strength and Flexibility
The company generated nearly $1.5 billion in annual operating cash flow, allowing for strategic capital allocation and sustained success.
UTHR Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
UTHR Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Jul 30, 2025 | $297.56 | $281.95 | -5.25% |
Apr 30, 2025 | $300.76 | $303.09 | +0.77% |
Feb 26, 2025 | $357.50 | $318.89 | -10.80% |
Oct 30, 2024 | $352.80 | $361.40 | +2.44% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does United Therapeutics (UTHR) report earnings?
United Therapeutics (UTHR) is schdueled to report earning on Oct 29, 2025, Before Open (Confirmed).
What is United Therapeutics (UTHR) earnings time?
United Therapeutics (UTHR) earnings time is at Oct 29, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is UTHR EPS forecast?
UTHR EPS forecast for the fiscal quarter 2025 (Q3) is 7.31.